Prior authorization delays lead to serious harm for people with cancer, nationwide survey finds

byAmerican Society for Radiation OncologyCredit: American Society for Radiation OncologyA new nationwide survey of more than 750 radiation oncologists confirms that prior authorization harms peo

Updated on: December 19,2024

Prior authorization delays lead to serious harm for people with cancer, nationwide survey finds

byAmerican Society for Radiation OncologyCredit: American Society for Radiation OncologyA new nationwide survey of more than 750 radiation oncologists confirms that prior authorization harms peo

Updated on:December 19,2024

Study reveals immune-modulatory mechanism of lurbinectedin in small-cell lung cancer

byThe Mount Sinai HospitalLurbinectedin augments the anti-tumor immune response of PD-L1 blockade in immunocompetent SCLC models. Credit:Cell Reports Medicine(2024). DOI: 10.1016/j.x

Updated on: January 21,2025

Study reveals immune-modulatory mechanism of lurbinectedin in small-cell lung cancer

byThe Mount Sinai HospitalLurbinectedin augments the anti-tumor immune response of PD-L1 blockade in immunocompetent SCLC models. Credit:Cell Reports Medicine(2024). DOI: 10.1016/j.x

Updated on:January 21,2025

Researchers design novel immunotherapy for brain cancer

byThe Wistar InstituteCredit: Unsplash/CC0 Public DomainThe Wistar Institute's David B. Weiner, Ph.D.—Executive Vice President, director of the Vaccine & Immunotherapy Center and W.W. Sm

Updated on: December 20,2024

Researchers design novel immunotherapy for brain cancer

byThe Wistar InstituteCredit: Unsplash/CC0 Public DomainThe Wistar Institute's David B. Weiner, Ph.D.—Executive Vice President, director of the Vaccine & Immunotherapy Center and W.W. Sm

Updated on:December 20,2024

Overcoming glioblastoma resistance to chemotherapy

byInstitute for Basic ScienceThe "onion model" illustrates how the one-by-one inactivation of the DNA repair pathways brings about changes in TMZ-induced mutational signatures. Every &

Updated on: January 23,2025

Overcoming glioblastoma resistance to chemotherapy

byInstitute for Basic ScienceThe "onion model" illustrates how the one-by-one inactivation of the DNA repair pathways brings about changes in TMZ-induced mutational signatures. Every &

Updated on:January 23,2025

Colorectal cancer risk factors important to consider for rescreening interval

by Lori SolomonColorectal cancer (CRC) risk factors are important to consider when making decisions for colonoscopy rescreening following negative colonoscopy screening (NCS) results (no presence of C

Updated on: December 21,2024

Colorectal cancer risk factors important to consider for rescreening interval

by Lori SolomonColorectal cancer (CRC) risk factors are important to consider when making decisions for colonoscopy rescreening following negative colonoscopy screening (NCS) results (no presence of C

Updated on:December 21,2024

Algorithm helps guide cancer treatment using circulating tumor DNA from blood samples

byPeter MacCallum Cancer CentreCredit: Pixabay/CC0 Public DomainA breakthrough by researchers at Peter Mac will allow scientists to detect, analyze and profile cancer tumors in patients via a si

Updated on: December 20,2024

Algorithm helps guide cancer treatment using circulating tumor DNA from blood samples

byPeter MacCallum Cancer CentreCredit: Pixabay/CC0 Public DomainA breakthrough by researchers at Peter Mac will allow scientists to detect, analyze and profile cancer tumors in patients via a si

Updated on:December 20,2024

New toolkit to support the collection of cancer-patient-reported outcome measures

byUniversity of Strathclyde, GlasgowCredit: Pixabay/CC0 Public DomainA new Scotland-wide toolkit is supporting the collection of patient-reported outcome measures (PROMs) to understand the impac

Updated on: December 19,2024

New toolkit to support the collection of cancer-patient-reported outcome measures

byUniversity of Strathclyde, GlasgowCredit: Pixabay/CC0 Public DomainA new Scotland-wide toolkit is supporting the collection of patient-reported outcome measures (PROMs) to understand the impac

Updated on:December 19,2024

Co-located cell types help drive aggressive brain tumors, study finds

Updated on: March 27,2025

Co-located cell types help drive aggressive brain tumors, study finds

Updated on:March 27,2025

Opioids interfere with cancer immunotherapy, but another type of drug could help

byUniversity of PittsburghCredit: Etatics Inc. from PexelsOpioids are often first-line treatments for cancer-related pain, but they can suppress the immune system and reduce the effectiveness of

Updated on: December 20,2024

Opioids interfere with cancer immunotherapy, but another type of drug could help

byUniversity of PittsburghCredit: Etatics Inc. from PexelsOpioids are often first-line treatments for cancer-related pain, but they can suppress the immune system and reduce the effectiveness of

Updated on:December 20,2024

Cancer's ripple effect may promote blood clot formation in the lungs

Updated on: March 27,2025

Cancer's ripple effect may promote blood clot formation in the lungs

Updated on:March 27,2025

Urine test uses 'zombie' cell proteins for early detection of lung cancer

Credit: Pixabay/CC0 Public DomainScientists in the United Kingdom have created a world-first urine test that could indicate the first possible signs of lung cancer.Lung cancer is the third most common

Updated on: December 20,2024

Urine test uses 'zombie' cell proteins for early detection of lung cancer

Credit: Pixabay/CC0 Public DomainScientists in the United Kingdom have created a world-first urine test that could indicate the first possible signs of lung cancer.Lung cancer is the third most common

Updated on:December 20,2024

Auto hematopoietic cell transplant not beneficial for mantle cell lymphoma with undetectable residual disease

by Elana GotkineAutologous hematopoietic cell transplant (auto-HCT) is not beneficial for patients with mantle cell lymphoma (MCL) in first complete remission (CR) with undetectable minimal residual d

Updated on: December 21,2024

Auto hematopoietic cell transplant not beneficial for mantle cell lymphoma with undetectable residual disease

by Elana GotkineAutologous hematopoietic cell transplant (auto-HCT) is not beneficial for patients with mantle cell lymphoma (MCL) in first complete remission (CR) with undetectable minimal residual d

Updated on:December 21,2024